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Letter to the Editor
Significant Association between Epilepsy and Presence of Onchocercal Nodules:
Case-Control Study in Cameroon
Dear Sir:
The relationship between epilepsy and onchocerciasis has
for a long time attracted the interest of neurologists, parasi-
tologists, epidemiologists, and public health policy makers.
Meta-analyses of community data have shown an ecological
association between the two diseases
1; however, most studies
conducted at the individual level (case-control studies) led to
inconclusive evidence on this association.
2 In the latest study
to date, Kaiser and others
3 conducted a case-control analysis
in a group of subjects living in a Ugandan onchocerciasis
focus.
3 A total of 38 patients with epilepsy (PWE) were
matched by time and place of residence and gender (except
for 5 patients) to 38 control individuals. Kaiser and others
3
tested the hypothesis that onchocerciasis is related to epilepsy
by comparing three indicators of Onchocerca volvulus infec-
tion between the two groups of individuals: presence of skin
microfilariae and presence and number of subcutaneous
nodules. Kaiser and others
3 found that the presence of
microfilariae in the skin of epilepsy patients was insignifi-
cantly elevated compared with controls, but because most of
their study subjects had received ivermectin 10–12 months
before the study, the comparison of infection rates based on
skin biopsies may lack robustness. Besides this finding, Kaiser
and others
3 observed a trend for both a higher proportion of
nodule carriers (P = 0.065, Mantel–Haenszel c
2 test) and a
higher mean number of nodules per individual (P = 0.061,
Kruskal–Wallis test) in the PWEs than controls. In the discus-
sion section of their article, Kaiser and others
3 were eager to
know whether similar observations had been made during the
case-control study that we conducted in central Cameroon in
2001 of 144 ivermectin-naı ¨ve individuals.
4 In our article, we
showed that the skin O. volvulus microfilarial density was
more than two times higher in the 72 PWEs than in their
72 controls matched on age, sex, and village of residence, but
we did not provide comparisons based on nodule palpation.
4
After the call for information in the work by Kaiser and
others,
3 we reanalyzed our database, which also included
information on subcutaneous nodules. In our study, the num-
ber of individuals showing at least one palpable nodule was
31 (43.1%) in the control group and 49 (68.1%) in the PWE
group. McNemar test of proportion for paired samples
showed that onchocercal nodules were more frequent in
PWEs than controls (P = 0.0055). From this difference, we
calculated that individuals with at least one nodule have more
than two times the risk of belonging to the PWE group
than individuals showing no palpable nodules (odds ratio =
2.5, 95% confidence interval = 1.24–5.36). In some villages
included in our study, the nodules were not only searched for
their presence versus absence but also carefully counted;
thus, the total number of nodules per individual was available
for a subset of 22 pairs of persons. The mean number of
nodules per individual was lower in controls (mean = 0.82,
standard deviation = 1.30) than PWEs (mean = 1.14, standard
deviation = 1.04), but t test for paired samples did not show
statistical significance (P = 0.1872). These results corroborate
the trend observed in the work by Kaiser and others,
3 which
suggests that the presence of onchocercal nodules is asso-
ciated with epileptic status. Because microfilarial density
is expected to be higher in persons harboring palpable
onchocercal nodules than in apparently nodule-free people,
5
our observations support the hypothesis that intensity of
infection with O. volvulus is involved in the pathogenesis
of onchocerciasis-related epilepsy.
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